# Autologous Bone Marrow Stem Cells in Ischemic Stroke.

> **NCT00535197** · PHASE1,PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 5 (actual)

## Conditions studied

- Stroke, Acute
- Infarction, Middle Cerebral Artery

## Interventions

- **BIOLOGICAL:** Infusion of autologous CD34+ stem cells into middle cerebral artery

## Key facts

- **NCT ID:** NCT00535197
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535197, "Autologous Bone Marrow Stem Cells in Ischemic Stroke.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00535197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*